IPP Bureau
API exports surpass imports by value in 2020-21
By IPP Bureau - August 03, 2021
The govt has rolled out three schemes for promoting the manufacture of API
Drug exports grow on the back of govt support
By IPP Bureau - August 03, 2021
Drug formulations and biologics make impressive gains
AYUSH 64 effective in mild and moderate COVID 19
By IPP Bureau - August 03, 2021
It works as an adjunct to standard care based on robust clinical trials
Glenmark signs agreement with SaNOtize to manufacture NONS
By IPP Bureau - August 02, 2021
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
Ajanta Pharma aims to file 10-12 ANDAs per annum
By IPP Bureau - August 02, 2021
India business is growing as per projections; whereas US business will bounce back soon.
Granules India earmarks Rs 400 crore as Capex for FY 22
By IPP Bureau - August 02, 2021
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Clinical trials in the UK to study the efficacy of Ashwagandha on COVID 19 patients
By IPP Bureau - August 02, 2021
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
PI Industries acquires API business of Ind Swift Laboratories
By IPP Bureau - August 02, 2021
Turnover of API division of ISLL stood at Rs 856.58 crore
Takeda and Frazier Healthcare Partners collaborates for Norovirus vaccine candidate
By IPP Bureau - August 02, 2021
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
Bharat Biotech gets WHO prequalification for ROTAVAC 5D
By IPP Bureau - August 02, 2021
WHO prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO
Windlas Biotech opens for subscription this week
By IPP Bureau - August 02, 2021
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
Krsnaa Diagnostics public issue opens from Aug 4-6th 2021
By IPP Bureau - August 02, 2021
Price band in the range of Rs 933 to Rs 954
Ajanta Pharma Q1FY22 consolidated net profit up at Rs. 173.75 Cr
By IPP Bureau - August 01, 2021
It posted net profit of Rs.147.76 crores for the period ended June 30, 2020.
Unichem Laboratories Q1FY22 consolidated loss at Rs. 11.48 Cr
By IPP Bureau - August 01, 2021
The company posted net profit of Rs.2.43 crores for the period ended June 30, 2020.
Zydus Cadila receives approval from USFDA for Fulvestrant Injection
By IPP Bureau - July 31, 2021
The group now has 320 approvals and has so far filed over 400 ANDAs
